Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: fournier g. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314
Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
Payrard-Starck C, Fourcade A, An Nguyen T, Tissot V, Doucet L, Marolleau J, Lucas C, Fournier G, Valeri A. Payrard-Starck C, et al. Among authors: fournier g. Prog Urol. 2023 Apr;33(5):265-271. doi: 10.1016/j.purol.2023.01.004. Epub 2023 Feb 4. Prog Urol. 2023. PMID: 36740508 Clinical Trial.
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Mjaess G, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S, Diamand R. Mjaess G, et al. Among authors: fournier g. Eur Urol Focus. 2023 Nov;9(6):992-999. doi: 10.1016/j.euf.2023.04.008. Epub 2023 May 3. Eur Urol Focus. 2023. PMID: 37147167
Impact of age on the Quadrella index assessing oncological and functional results after prostate brachytherapy: A 6-year analysis.
Tremblay G, Nguyen TA, Marolleau J, Malhaire JP, Fourcade A, Boussion N, Goasduff G, Martin E, Dissaux G, Pradier O, Fournier G, Schick U, Valeri A. Tremblay G, et al. Among authors: fournier g. J Contemp Brachytherapy. 2023 Apr;15(2):89-95. doi: 10.5114/jcb.2023.127049. Epub 2023 Apr 28. J Contemp Brachytherapy. 2023. PMID: 37215618 Free PMC article.
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Bourgeno HA, Jabbour T, Baudewyns A, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Vlahopoulos L, Guenzel K, Roumeguère T, Peltier A, Diamand R. Bourgeno HA, et al. Among authors: fournier g. Eur Urol Oncol. 2024 Jan 24:S2588-9311(24)00031-2. doi: 10.1016/j.euo.2024.01.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38272745
496 results